[gtranslate]

Overcoming Treatment Challenges With Cell And Gene Therapies

Gene and cell therapies have the potential to revolutionize healthcare by reprogramming the immune system to treat diseases that are difficult to address with traditional medicine. These therapies involve introducing, replacing, or deactivating genes in cells, either inside or outside the body. For instance, Novartis’ Zolgensma® uses a virus-based gene therapy to deliver a functional […]

Transforming healthcare: 4D Lifetec’s revolutionary approach to early cancer detection

In the rapidly advancing landscape of healthcare, 4D Lifetec emerges as a trailblazer, aiming to redefine the paradigm of early cancer detection. At the forefront of this innovative journey is the Lifetest™, a user-friendly and proprietary immunological liquid biopsy assay. All that is needed is a few drops of blood. This breakthrough technology, coupled with […]

Emmes Launches Cell and Gene Therapy Center

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research. The new center will focus on supporting the clinical trials of our clients who are developing cell […]

New UK Biotech Centres To Boost Cell And Gene Therapies

The National Health Service Blood and Transplant from the UK, which takes care of blood as well as platelet donations as well as organ, stem cell, and tissue transplants in the country, has come up with a new clinical biotech centre so as to boost the UK’s capacity when it comes to making DNA plasmids […]

Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition

uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc. The cell & gene therapy (CGT) CDMO has an established global footprint with two GMP manufacturing facilities in China and its headquarters […]

Lack of Experience Hinders CDMOs In Cell And Gene Therapy

CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of companies preparing to scale up their cell and gene therapy manufacturing for Phase III trials and commercialization. While physical capacity has been blamed, the real issue lies in the lack of experience. Manufacturing novel products requires process innovation, but advanced […]

Understanding How Suboxone Causes Tooth Decay

Suboxone is a medication widely prescribed by doctors for its effectiveness in treating opioid addiction. Its benefit to people suffering from opioid dependence and addiction is undeniable; however, it has a hidden danger that most people don’t know about. The medication is a combination of buprenorphine, a partial opioid agonist, with naloxone, an opioid antagonist. […]

Chemspec Europe 2024: Connect with the world of fine and speciality chemicals

The Ticket Shop is now open for Chemspec Europe 2024 – The key marketplace for fine and speciality chemicals, bespoke solutions, services, and equipment. Taking place from 19 – 20 June 2024 at the Messe Düsseldorf exhibition centre in Germany, Chemspec Europe is the meeting point to find new suppliers, enhance existing business relationships, network […]

Мы готовы ответить на ваши вопросы и помочь с любыми запросами

Оставьте свои контакты, и мы свяжемся с вами в ближайшее время

Контактные данные
Предварительное время
Инфарма Казахстан
Обзор конфиденциальности

На этом сайте используются файлы cookie, что позволяет нам обеспечить наилучшее качество обслуживания пользователей. Информация о файлах cookie хранится в вашем браузере и выполняет такие функции, как распознавание вас при возвращении на наш сайт и помощь нашей команде в понимании того, какие разделы сайта вы считаете наиболее интересными и полезными.